Egido-Moreno S,
Valls-Roca-Umbert J, Jané-Salas E, López-López J, Estrugo-Devesa A. COVID-19
and oral lesions, short communication and review. J Clin Exp Dent.
2021;13(3):e287-94.
doi:10.4317/jced.57981
https://doi.org/10.4317/jced.57981
___________
References
|
1.
Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan,
China: challenges for global health governance. JAMA. 2020;323:709-10. |
|
|
|
|
|
2.
OMS. Coronavirus disease (COVID-19). Accessed 17-10-20: https://www.who.int |
|
|
|
|
|
3.Tang
K, Wang Y, Zhang H, Zheng Q, Fang R, Sun Q. Cutaneous manifestations of the
coronavirus disease 2019 (COVID-19): A brief review. Dermatol Ther. 2020;7:e13528. |
|
|
|
|
|
4.
Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P,
Fernández Nieto D, Rodríguez-Villa Lario A, et al. Classification of the
cutaneous manifestations of COVID-19: a rapid prospective nationwide
consensus study in Spain with 375 cases. Br J Dermatol. 2020;183:71-77. |
|
|
|
|
|
5.
Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur
Acad Dermatol Venereol. 2020;34:e212-3. PMid:32215952 |
|
|
|
|
|
6.
Martín Carreras-Presas C, Amaro Sánchez J, López Sánchez AF, Jané Salas E,
Somacarrena Pérez ML. Oral vesiculobullous lesions associated with SARS-CoV-2
infection. Oral vesiculobullous lesions associated with SARS-CoV-2 infection.
Oral Dis. 2020 May 5;10.1111/odi.13382. Online ahead of print. |
|
|
|
|
|
7.
Amorim dos Santos J, Normando AGC, Silva RLCD, de Paula RM, Cembranel AC,
Santos-Silva AR, et al. Oral mucosa lesions in a Covid-19 patient: new signs
or secondary manifestations? Int J Infect Dis. 2020;97:326-8. |
|
|
|
|
|
8.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred Reporting
Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS
Med. 2009;6:e1000097. |
|
|
|
|
|
9.
The University of ADELAIDE. Joanna Briggs Institute. JBI critical appraisal
checklist for case reports. Adelaide, SA: The Joanna Briggs Institute; 2016. Accessed
10-10-20: https://joannabriggs.org/critical-appraisal-tools. |
|
|
|
|
|
10.
Oxford Centre for Evidence-based Medicine (2009). Oxford Centre for
Evidence-based Medicine - Levels of Evidence. Accessed 6-9-20. Retrieved from
https:// www.cebm.net/2009/06/oxford-centre-evidence-based-medi-
cine-levels-evidence-march-2009/ |
|
|
|
|
|
11.
Ansari R, Gheitani M, Heidari F, Heidari F. Oral cavity lesions as a
manifestation of the novel virus (COVID-19). Oral Dis. 2020 Jun 8. Online
ahead of print. |
|
|
|
|
|
12.
Chaux-Bodard AG, Deneuve S, Desoutter A. Oral manifestation of Covid-19 as an
inaugural symptom? J Oral Med Oral Surg 2020;26:10. |
|
|
|
|
|
13.
Cebeci Kahraman F, Çaşkurlu H. Mucosal involvement in a COVID-19-positive
patient: a case report. Dermatol Ther. 2020;33:e13797. |
|
|
|
|
|
14.
Ciccarese G, Drago F, Boatti M, Porro A, Muzic SI, Parodi A. Oral erosions
and petechiae during SARS-CoV-2 infection. J Med Virol. 2021;93:129-132. |
|
|
|
|
|
15.
Díaz Rodríguez M, Jiménez Romera A, Villarroel M. Oral manifestations
associated with COVID-19. Oral Dis. 2020 Jul 22;10.1111/odi.13555. Online
ahead of print. |
|
|
|
|
|
16.
Glavina A, Biočina-Lukenda D, Mravak-Stipetić M, Markeljević J. Oral symptoms
and lesions in SARS-CoV-2-positive patient. Oral Dis. 2020 Aug
9;10.1111/odi.13596. Online ahead of print. |
|
|
|
|
|
17.
Jiménez-Cahué J, Ortega-Quijano D, Carretero-Barrio I, Suárez-Valle A,
Saceda-Corralo D, Moreno-García del Real C, et al. Erythema multiforme-like
eruption in patients with COVID-19 infection: clinical and histological findings.
Clin Exp Dermatol. 2020;45:892-895. |
|
|
|
|
|
18.
Labé P, Ly A, Sin C, Nasser M, Chapelon-Fromont E, Ben Saïd P, Mahé E.
Erythema multiforme and Kawasaki disease associated with COVID-19 infection
in children. Dermatol Venereol. 2020;34:e539-41. |
|
|
|
|
|
19.
Patel J, Woolley J. Necrotizing periodontal disease: Oral manifestation of
COVID-19. Oral Dis. 2020 Jun 7;10.1111/odi.13462. Online ahead of print. |
|
|
|
|
|
20.
Riad A, Kassem I, Hockova B, Barah M, Klugar M. Tongue ulcers associated with
SARS-CoV-2 infection: A case series. Oral Dis. 2020 Sep 5. Online ahead of
print. |
|
|
|
|
|
21.
Sakaida T, Tanimoto I, Mtsubara A, Nakamura M, Morita A. Unique skin
manifestations of COVID-19: Is drug eruption specific to COVID-19? J Dermatol
Sci. 2020;99:62-4. |
|
|
|
|
|
22.
Soares CD, Carvalho RA, Carvalho KA, Carvalho MG, Almeida OP. Letter to
Editor: Oral lesions in a patient with Covid-19. Med Oral Patol Oral Cir
Bucal. 2020;25:e563-4. |
|
|
|
|
|
23.
Tomo S, Miyahara GI, Simonato LE. Oral mucositis in a SARS-CoV-2-infected
patient: Secondary or truly associated condition? Oral Dis. 2020 Jul 29.
Online ahead of print. |
|
|
|
|
|
24.
Corchuelo J, Ulloa FC. Oral manifestations in a patient with a history of
asymptomatic COVID-19: Case report. Int J Infect Dis. 2020;100:154-7. |
|
|
|
|
|
25.
Cruz Tapia RO, Peraza Labrado AJ, Guimaraes DM, Matos Valdez LH. Oral mucosal
lesions in patients with SARS-CoV-2 infection. Report of four cases. Are they
a true sign of COVID-19 disease? Spec Care Dentist. 2020;40:555-560. |
|
|
|
|
|
26.
Kitakawa D, Oliveira FE, Neves de Castro P, Carvalho LFCS. Short report -
Herpes simplex lesion in the lip semimucosa in a COVID-19 patient. Eur Rev
Med Pharmac Sci. 2020;24:9151-3. PMid:32965008 |
|
|
|
|
|
27.
Brandão TB, Gueiros LA, Melo TS, Prado-Ribeiro AC, Nesrallah ACFA, Prado GVB,
et al. Oral lesions in patients with SARS-CoV-2 infection: could the oral
cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;S2212-4403:31119-6. PMid:32888876
PMCid:PMC7434495 |
|
|
|
|
|
28.
Amorim dos Santos J, Normando AGC, Carvalho da Silva RL, Acevedo AC, de Luca
Canto G, Sugaya N, et al. Oral Manifestations in Patients with COVID-19: A
Living Systematic Review. J Dent Res. 2021;100:141-154. |
|
|
|
|
|
29.
Petrescu N. Lucaciu O, Roman A. Oral mucosa lesions in COVID-19. Oral Dis. 2020
Jun 19;10.1111/odi.13499. Online ahead of print. |
|
|
|
|
|
30.
Riad A, Klugar M, Krsek M. COVID-19 Related Oral Manifestations, Early Disease
Features? Oral Dis. 2020 Jun 30;10.1111/odi.13516. Online ahead of print. |
|
|
|
|
|
31.
Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen Q. High expression
of ACE2 receptor of 2019-n-Cov on the ephitelial cells of oral mucosa. Int J
oral Sci. 2020;12:8. |
|
|
|
|
|
32.
Burgos Ponce J, Trijoe KC. Overlapping findings or oral manifestations in new
SARS- CoV-2 infection. Oral Dis. 2020 Jun 10;10.1111/odi.13478. Online ahead
of print. |
|
|
|
|
|
33.
de Carvalho LFDCES, Kitakawa D, Cabral LAG. Oral lesions of herpes zoster in
COVID-19 patients or truly associated to the disease? Oral Dis. 2020 Jun
10;10.1111/odi.13472. Online ahead of print. |
|
|
|
|
|
34.
Bradan Z, Gaudin A, Struillou X, Amador G, Sueidan A. Periodontal pockets: A
potential reservoir for SARS-CoV-2? Med Hypotheses. 2020;143:109907. |
|